GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KIT, MET, NR1H4, PPARA, TBXAS1 |
12.351 |
[BP] GO:0065008 |
regulation of biological quality
|
ABCB1, ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F10, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KDR, KIT, MET, NR1H4, POLA1, POLB, PPARA, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
11.5074 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, NR1H4 |
11.4079 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.8176 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TYR, XDH |
10.3706 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, FABP3, FUT7, GBA2, HSD17B3, NR1H4, PIM1, PPARA, TBXAS1, TYR, XDH |
10.1332 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.1176 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, GPER1, HCAR2, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
9.93912 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, FLT3, GPER1, HCAR2, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
9.91063 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AR, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, FABP3, GPER1, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR1H4, POLB, PPARA, SRC, TYR |
9.61716 |
[BP] GO:0010033 |
response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, NR1H4, POLB, PPARA, SRC, TYR |
9.21524 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, NR1H4 |
8.89636 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
8.87145 |
[BP] GO:0042221 |
response to chemical
|
ABCB1, ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, GPER1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP2, MMP9, NR1H4, POLB, PPARA, SRC, TERT, TYR |
8.66031 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, FABP3, FABP4, FLT3, FUT7, GBA2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP2, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TYR, XDH |
8.4884 |
[BP] GO:0009719 |
response to endogenous stimulus
|
ADRA2A, AKR1B1, ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DNMT1, DRD1, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, IGF1R, KIT, MMP2, NR1H4, PPARA, SRC |
8.15309 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PPARA, SRC, THRA, THRB |
7.87604 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PIM1, PPARA, SRC, THRA, THRB |
7.76032 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
7.49014 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DAO, DRD1, DRD2, GBA2, HSD17B3, NR1H4, TYR |
7.41989 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AR, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, HSD17B2, NR1H4, SRC, TYR |
7.35239 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, TBXAS1, TYR, XDH |
7.35239 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
7.34165 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F10, F3, FLT3, GPER1, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
7.31628 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, ADRA2A, AKR1B1, APP, AR, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DNMT1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, GPER1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, SRC, TERT, XDH |
7.28645 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESR2, F10, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTPN1, PTPRS, SRC, TERT, THRA, TNKS, TNKS2, XDH |
7.28058 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
7.18514 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BACE1, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESR2, F10, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTPN1, PTPRS, SRC, TERT, THRA, TNKS, TNKS2, XDH |
7.13045 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PPARA, SRC, THRA, THRB |
6.84463 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TYR, XDH |
6.83968 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, KIT, MMP9, SRC, TERT |
6.83548 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
6.79244 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, ADRA2A, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, GPER1, HCAR2, KDR, NR1H4, SRC, TNKS, TNKS2 |
6.68046 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AR, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, HSD17B3, KDR, KIT, POLB, PPARA, PTPRS, SRC, THRA, TYR |
6.68046 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
6.57529 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, GPER1, HSD11B2, SRC, TYR |
6.57126 |
[BP] GO:0015711 |
organic anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, NR1H4, PPARA |
6.53442 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
6.51815 |
[BP] GO:0048518 |
positive regulation of biological process
|
ABCB1, ACHE, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
6.43712 |
[BP] GO:0009725 |
response to hormone
|
ADRA2A, AKR1B1, ALPL, AR, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, GPER1, HSD11B2, KIT, PPARA, SRC |
6.43712 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
6.37213 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, KIT, MET, MMP2, MMP9, PIM1, POLB, PPARA, PTPRS, SRC, TERT, THRA, THRB, TNKS2, TYR |
6.35239 |
[BP] GO:0032879 |
regulation of localization
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APP, AR, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA |
6.26734 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, MMP9, NR1H4, SRC, TERT |
6.26223 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2, HSD17B3 |
6.26223 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
6.24454 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
6.23515 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, FABP3, FABP4, FUT7, GBA2, KIT, MET, PPARA, TBXAS1 |
6.20527 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CYP1B1, DRD2, F10, F3, FLT3, GPER1, KDR, KIT, MET, PTPN1, SRC, XDH |
6.11605 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
ADRA2A, AKR1B1, AR, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, ESR1, F3, FLT3, GPER1, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, TERT |
6.07817 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
6.03418 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ADRA2A, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
6.01525 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TYR, XDH |
5.99845 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESRRA, F10, F3, FABP4, FLT3, GPER1, KDR, KIT, MET, MMP12, MMP2, MMP9, NR1H4, PTPN1, SRC, TERT, TNKS, TNKS2, XDH |
5.94002 |
[BP] GO:0071310 |
cellular response to organic substance
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, NR1H4, SRC |
5.9067 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
5.84789 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, ESR1, F10, F3, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PTPN1, SRC, XDH |
5.82101 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
5.80634 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AR, AXL, BCL2, CA2, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, HSD17B3, KDR, KIT, MMP9, PIM1, POLB, PPARA, PTPRS, SRC, THRA, TYR |
5.79139 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ABCB1, ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, F10, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, PTPRS, SRC, TERT, THRA, TNKS, TNKS2, XDH |
5.58297 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
5.53283 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AR, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F10, F3, FABP4, GPER1, HSD11B2, HSD17B2, IGF1R, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, SRC, THRA, THRB, TNKS2, TYR |
5.4992 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT, THRA, XDH |
5.4992 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT, THRA, XDH |
5.49748 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ADRA2A, APP, BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.47348 |
[BP] GO:0050896 |
response to stimulus
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA6, CA9, CDK6, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESRRA, F10, F3, FABP3, FABP4, FLT3, GPER1, HSD11B2, HSD17B2, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, NR1H4, POLA1, POLB, PPARA, PTPN1, SRC, TERT, THRA, TYR |
5.41601 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
5.34694 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, KDR, KIT, MMP9, NR1H4, PTPN1, SRC, XDH |
5.32909 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, GPER1, KDR, KIT, MMP9, NR1H4, PTPN1, SRC, XDH |
5.32909 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ADRA2A, APP, BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.31185 |
[BP] GO:0006820 |
anion transport
|
ABCB1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, FABP3, NR1H4, PPARA |
5.23713 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ADRA2A, APP, BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
5.16882 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.11509 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ADRA2A, ALOX15, AR, BCL2, CDK6, CYP19A1, DRD1, DRD2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
5.07513 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TBXAS1 |
5.07513 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ADRA2A, APP, BCL2, DRD1, F10, F3, GPER1, IGF1R, KDR, KIT, MET, MMP9, SRC, TERT |
4.99865 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
4.96416 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, ADRA2A, ADRA2C, AR, BCL2, DRD1, DRD2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, NR1H4, PTPN1, PTPRS, SRC, TERT, XDH |
4.92167 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, ADRA2A, ADRA2C, AR, BCL2, DRD1, DRD2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, NR1H4, PTPN1, PTPRS, SRC, TERT, XDH |
4.90188 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, DRD2, FLT3, GPER1, KDR, KIT, PTPN1, SRC, XDH |
4.77589 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, GPER1, HCAR2, NR1H4, TNKS, TNKS2 |
4.75993 |
[BP] GO:0051716 |
cellular response to stimulus
|
ADRA2A, AKR1B1, ALOX15, ALPL, APP, AR, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, ESR1, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP2, MMP9, NR1H4, POLA1, POLB, PTPN1, SRC, TERT |
4.73762 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DYRK1A, ESR1, ESR2, F10, F3, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PTPN1, PTPRS, SRC, TERT, THRA, TNKS, TNKS2, XDH |
4.71776 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, ADRA2A, CYP1A1, FABP3, FLT3, GPER1, HCAR2, KIT, NR1H4, PPARA, SRC, THRA |
4.70249 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, TBXAS1 |
4.66588 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.65493 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, PTPRS, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
4.64705 |
[BP] GO:0080134 |
regulation of response to stress
|
ABCB1, ADORA1, ADRA2A, APP, CDK6, CYP19A1, DRD2, DYRK1A, ESR1, F3, FABP4, GPER1, IGF1R, MET, MMP12, MMP2, NR1H4, PPARA, PTPN1, PTPRS, SRC, TERT, XDH |
4.61732 |
[BP] GO:0022414 |
reproductive process
|
ADRA2C, AKR1B1, ALPL, APP, AR, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, HSD17B3, KIT, MMP2, MMP9, SRC, THRA, THRB |
4.55476 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRA2A, AKR1B1, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, GPER1, MET, NR1H4, POLA1, POLB, SRC, TERT |
4.53614 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AXL, BCL2, CA2, CDK6, CHRM2, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, GPER1, HCAR2, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PTPRS, SRC, TERT, THRA, THRB, TNKS2, XDH |
4.4699 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT, THRA, XDH |
4.41658 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, KIT, MMP9, TERT |
4.37906 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT |
4.31407 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GBA2, NR1H4, PPARA, TBXAS1 |
4.3129 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, PIM1, SRC |
4.29951 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, ALOX15, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, PPARA, PTPN1, PTPRS, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
4.28269 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.20958 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, KIT, MET, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT |
4.18694 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
AR, ESR1, ESR2, ESRRA, ESRRB, NR1H4, PPARA, THRA, THRB |
4.15464 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, GPER1, KDR, SRC |
4.10794 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, ESRRB, FLT3, GPER1, KDR, KIT, MMP9, PTPN1, SRC, XDH |
4.10157 |
[BP] GO:0006940 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, GPER1, KIT |
4.07926 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, F10, F3, GPER1, KIT, MET, SRC, XDH |
4.06509 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HSD11B2, KIT, MMP2, POLB, PPARA, SRC, TERT, THRA, TYR |
4.02238 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP9, NR1H4, PPARA, PTPN1, SRC, XDH |
3.9682 |
[BP] GO:0045742 |
None
|
ADORA1, ADRA2A, ADRA2C, GPER1, MMP9 |
3.9665 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP9, NR1H4, PPARA, PTPN1, SRC, XDH |
3.91142 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DAO, DRD1, DRD2 |
3.89205 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP9, PPARA, PTPN1, SRC, XDH |
3.87471 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, POLB, PPARA, SRC, TERT |
3.87471 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, DRD2, FLT3, GPER1, IGF1R, KDR, KIT, PTPN1, SRC, XDH |
3.87254 |
[BP] GO:1901186 |
None
|
ADORA1, ADRA2A, ADRA2C, GPER1, MMP9 |
3.87211 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
3.79308 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, DRD2, GPER1, KIT |
3.75898 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, BACE1, CA2, CA7, DRD1, DRD2, GPER1, KIT |
3.75898 |
[BP] GO:0042493 |
response to drug
|
ABCB1, AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HSD11B2, KDR, POLB, SRC |
3.75657 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRA2A, ADRA2C, APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, GPER1, HCAR2, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, SRC, TERT |
3.75657 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, DNMT1, DRD2, ESR1, GPER1, IGF1R, KDR, KIT, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
3.74665 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD2, FLT3, GPER1, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.74665 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2, GPER1 |
3.713 |
[BP] GO:0007617 |
None
|
APP, DRD1, THRA, THRB |
3.6827 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, NR1H4, SRC |
3.6827 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DAO, DRD1, DRD2, TYR |
3.67606 |
[BP] GO:0051050 |
positive regulation of transport
|
ABCB1, ACHE, ADORA1, ADRA2A, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, GPER1, HCAR2, MMP12, NR1H4, SRC, TERT |
3.6564 |
[BP] GO:0008283 |
cell proliferation
|
ABCB1, ACHE, AR, AURKB, BCL2, CYP1A1, ESR1, FLT3, KIT, MET, PIM1, POLA1, SRC, TYR |
3.6564 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, POLB, PTPN1, PTPRS, SRC, TNKS, XDH |
3.6564 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AR, AXL, CDK6, CYP1B1, DNMT1, DRD1, ESR1, GPER1, IGF1R, MMP2, MMP9, NR1H4, SRC |
3.6564 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DAO, FABP3, GBA2, NR1H4, PIM1, PPARA, TBXAS1, TYR |
3.64685 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, BACE1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DAO, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.62581 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, FABP3, FLT3, GPER1, HSD11B2, IGF1R, MMP2, NR1H4, PPARA, SRC, TYR |
3.61842 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, FLT3, GPER1, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.58608 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AR, AURKB, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, MET, MMP12, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2 |
3.54668 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.54668 |
[BP] GO:0051049 |
regulation of transport
|
ABCB1, ACHE, ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, GPER1, HCAR2, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA |
3.5437 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, KDR, POLB, SRC |
3.54219 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.50219 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
ADRA2A, AKR1B1, APP, AR, DNMT1, DRD1, ESR1, FLT3, GPER1, IGF1R, KIT, MMP2, NR1H4, SRC |
3.47324 |
[BP] GO:0042058 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, GPER1, MMP9 |
3.47152 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ABCB1, ADORA1, ADRA2A, ADRA2C, APP, AR, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, GPER1, KIT, MET, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
3.46549 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC, TERT |
3.44344 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, F3, FLT3, GPER1, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.43888 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.42223 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.42223 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DAO, DRD1, DRD2, DYRK1A, ESR1, F10, F3, FLT3, FUT7, GBA2, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLB, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2, TYR, XDH |
3.41687 |
[BP] GO:0051953 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD2 |
3.39833 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.38124 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, ADRA2A, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, HCAR2, IGF1R, KDR, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
3.36059 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, PPARA, SRC, TERT |
3.35947 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, POLB, PTPN1, PTPRS, SRC, TNKS, XDH |
3.35947 |
[BP] GO:0050994 |
None
|
ADORA1, ADRA2A, HCAR2, PPARA, THRA |
3.34557 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.33671 |
[BP] GO:0048608 |
reproductive structure development
|
AR, AXL, BCL2, CYP19A1, ESR1, HSD17B2, HSD17B3, KIT, SRC |
3.33244 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.33244 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DYRK1A, ESR1, GPER1, IGF1R, MET, MMP9, NR1H4, PTPN1, SRC, XDH |
3.3272 |
[BP] GO:0032845 |
None
|
ADORA1, ADRA2A, BCL2, DRD2, SRC, TNKS, TNKS2 |
3.30715 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD2, DYRK1A, ESR1, F3, FLT3, GPER1, KDR, KIT, MMP9, PTPN1, SRC, XDH |
3.295 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT |
3.295 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, DRD2, FABP3, FLT3, GPER1, HSD11B2, IGF1R, MMP2, NR1H4, PPARA, SRC, TYR |
3.28414 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, AR, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, GPER1, SRC |
3.28414 |
[BP] GO:0009987 |
cellular process
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPER1, HCAR2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TUBB3, TYR, XDH |
3.27199 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, KDR, MET, MMP12, NR1H4, PPARA, SRC, TERT, THRA, THRB, TNKS, TNKS2 |
3.25918 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, ADRA2A, APP, AURKB, CSNK2A1, CYP1B1, DRD2, ESR1, FABP4, IGF1R, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TNKS |
3.25918 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, APP, AR, AXL, BCL2, CA1, CA2, CDK6, CHRM2, CSNK2A1, CYP1B1, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP2, MMP9, NR1H4, PIM1, POLB, PPARA, PTPN1, SRC, THRA, THRB, TNKS, TNKS2 |
3.19343 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DAO, FABP3, GBA2, NR1H4, PIM1, PPARA, TBXAS1, TYR |
3.18772 |
[BP] GO:0045934 |
None
|
ADRA2A, AR, AURKB, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, MMP12, NR1H4, PPARA, SRC, TERT, THRA, THRB, TNKS, TNKS2 |
3.18748 |
[BP] GO:1901184 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, GPER1, MMP9 |
3.18407 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, KIT, PPARA, SRC |
3.18407 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
ADRA2A, AR, BCL2, DRD2, DYRK1A, ESR1, ESR2, GPER1, IGF1R, MET, MMP12, MMP9, NR1H4, PTPN1, PTPRS, SRC, TERT, XDH |
3.18177 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TERT, TNKS, TNKS2 |
3.11606 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, AR, BCL2, CA2, FLT3, GPER1, HSD11B2, SRC |
3.11324 |
[BP] GO:0007188 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, DRD1, DRD2, GPER1 |
3.11324 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, DAO, FABP3, GBA2, NR1H4, PIM1, PPARA, TBXAS1, TYR |
3.11092 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1, HSD17B3 |
3.10954 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AR, AURKB, AXL, BCL2, CSNK2A1, IGF1R, KDR, MMP9, NR1H4, PIM1, PTPN1, SRC, TERT |
3.10893 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
3.07813 |
[BP] GO:0019098 |
None
|
APP, DRD1, THRA, THRB |
3.05436 |
[BP] GO:0007176 |
None
|
ADORA1, ADRA2A, ADRA2C, APP |
3.05436 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX15, CYP19A1, CYP3A4, DAO, HSD17B3, TYR |
3.02154 |
[BP] GO:0035265 |
organ growth
|
AR, BCL2, CYP19A1, ESR1 |
2.99947 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, DYRK1A, F10, FLT3, IGF1R, KDR, KIT, MET, NR1H4, SRC, TNKS |
2.98537 |
[BP] GO:2001225 |
regulation of chloride transport
|
ABCB1, CA2, CA7 |
2.98281 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.98281 |
[BP] GO:0050730 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, FLT3, KIT, PTPN1, SRC |
2.97317 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ADRA2A, ADRA2C, ALOX15, APP, AR, BCL2, CDC25B, DNMT1, DRD1, DRD2, DYRK1A, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MMP9, PTPN1, SRC, XDH |
2.91987 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, GPER1, KDR, MET, MMP12, NR1H4, PPARA, PTPRS |
2.90445 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
2.89761 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AR, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, GPER1, IGF1R, MET, MMP12, NR1H4, PPARA, SRC, TERT, THRA, THRB, TNKS, TNKS2 |
2.89101 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AR, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, KDR, KIT, MET, MMP2, MMP9, PTPRS, SRC, TERT, THRA, THRB |
2.89101 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, DRD2, GPER1, MMP12, NR1H4, PPARA |
2.89101 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9, THRA |
2.88263 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
2.86546 |
[BP] GO:0060736 |
prostate gland growth
|
AR, CYP19A1, ESR1 |
2.86546 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, ADRA2A, ADRA2C, FLT3, KIT, PTPN1, SRC |
2.86546 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ADRA2C, APP, AR, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, GPER1, KDR, KIT, NR1H4, PIM1, SRC, TERT, THRA |
2.85913 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
ADRA2A, APP, AR, AURKB, BCL2, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, MET, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
2.85913 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
APP, AR, AURKB, DRD2, ESR1, ESR2, ESRRA, ESRRB, GPER1, IGF1R, KDR, MET, MMP12, NR1H4, PPARA, SRC, TERT, THRA, THRB, TNKS, TNKS2 |
2.83333 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CDK6, CYP19A1, DRD2, ESR1, ESRRA, GPER1, HCAR2, KIT, MMP12, MMP2, NR1H4, PTPN1, PTPRS, SRC |
2.82986 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, ADRA2A, ADRA2C, APP, AR, BCL2, CSNK2A1, DRD2, GPER1, HCAR2, MMP12, NR1H4, PTPN1, SRC, TERT, THRA |
2.82038 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC, TNKS |
2.79997 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, PPARA |
2.78201 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AR, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, HSD17B3, KIT, SRC |
2.77457 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, APP, CA2, DRD2, GPER1, HCAR2, MMP12, NR1H4, PTPN1, SRC, THRA |
2.76192 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
2.76192 |
[BP] GO:0045741 |
None
|
ADORA1, ADRA2A, ADRA2C |
2.76192 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, NR1H4, SRC |
2.76192 |
[BP] GO:0007189 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, GPER1 |
2.76192 |
[BP] GO:0008050 |
None
|
THRA, THRB |
2.75662 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.75662 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DAO, DRD1, DRD2 |
2.75582 |
[BP] GO:0007187 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, DRD1, DRD2, GPER1 |
2.74214 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, NR1H4, PPARA, SRC |
2.73607 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, DRD2, GPER1, HCAR2, MMP12, NR1H4, SRC |
2.72051 |
[BP] GO:0061097 |
None
|
ADORA1, ADRA2A, ADRA2C, APP, PTPN1 |
2.72051 |
[BP] GO:0048878 |
chemical homeostasis
|
ADRA2A, AKR1B1, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, GPER1, MET, NR1H4 |
2.67782 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, CHRM2, DRD2, GPER1, HCAR2, KIT, THRA, THRB |
2.67745 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.67745 |
[BP] GO:0033604 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.67745 |
[BP] GO:0051952 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, DRD2 |
2.67382 |
[BP] GO:0048806 |
genitalia development
|
AXL, CYP19A1, ESR1, HSD17B3 |
2.6577 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC, TERT, TNKS |
2.6413 |
[BP] GO:0065009 |
regulation of molecular function
|
ABCB1, ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, GPER1, IGF1R, KIT, MET, MMP9, NR1H4, PIM1, PPARA, PTPN1, SRC, TERT, TNKS, XDH |
2.6413 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, ADRA2A, ADRA2C, CYP19A1, DRD2, GPER1, HCAR2, NR1H4 |
2.6413 |
[BP] GO:0030518 |
intracellular steroid hormone receptor signaling pathway
|
AR, ESR1, ESR2, GPER1, SRC |
2.62694 |
[BP] GO:1904705 |
regulation of vascular smooth muscle cell proliferation
|
GPER1, MMP2, MMP9, TERT |
2.62011 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.58836 |
[BP] GO:0045833 |
None
|
ADORA1, ADRA2A, GPER1, HCAR2, NR1H4 |
2.5804 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AR, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, GPER1, IGF1R, KIT, MMP9, PTPN1, SRC, TERT, TNKS, XDH |
2.50981 |
[BP] GO:0070198 |
None
|
TERT, TNKS, TNKS2 |
2.50211 |
[BP] GO:0051172 |
None
|
ADRA2A, APP, AR, AURKB, CSNK2A1, DNMT1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, FABP4, GPER1, IGF1R, MMP12, MMP9, NR1H4, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
2.48695 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, ADRA2A, ADRA2C, DRD2, GPER1, HCAR2, MMP12, NR1H4, SRC |
2.48445 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD1, DRD2, GPER1, NR1H4, PPARA, PTPRS |
2.48083 |
[BP] GO:0048609 |
multicellular organismal reproductive process
|
AKR1B1, APP, AR, AXL, CYP1A1, DRD1, ESR1, KIT, SRC, THRA, THRB |
2.47996 |
[BP] GO:0006584 |
None
|
AKR1B1, DAO, DRD1, DRD2 |
2.47578 |
[BP] GO:0009712 |
None
|
AKR1B1, DAO, DRD1, DRD2 |
2.47578 |
[BP] GO:0061098 |
None
|
ADORA1, ADRA2A, ADRA2C, PTPN1 |
2.47578 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.43123 |
[BP] GO:0007200 |
None
|
ADRA2A, CHRM2, DRD1, DRD2, ESR1 |
2.43115 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRA2A, ADRA2C, CHRM2, DRD2, THRA, THRB |
2.43041 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.35558 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.35272 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.35272 |
[BP] GO:0006808 |
regulation of nitrogen utilization
|
BCL2, NR1H4 |
2.35272 |
[BP] GO:0019933 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, GPER1 |
2.35183 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, DRD2, ESR1, FABP4, GPER1, MMP12, MMP2, NR1H4, PPARA, PTPN1, PTPRS, SRC |
2.34898 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, GPER1, HCAR2, MMP12, NR1H4, SRC |
2.33258 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, KIT |
2.31138 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, F10, F3, KIT, MET, SRC |
2.29565 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.29472 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRA2A, ADRA2C, APP, AURKB, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, GPER1, KIT, PTPN1, SRC, TERT, TNKS, XDH |
2.29255 |
[BP] GO:0051090 |
regulation of DNA binding transcription factor activity
|
ADORA3, APP, AR, CYP1B1, ESR1, ESR2, KIT, NR1H4, PIM1 |
2.28907 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, GPER1, HSD11B2, SRC |
2.2575 |
[BP] GO:0003018 |
None
|
ADORA1, ADRA2A, ADRA2C, DRD1, GPER1, SRC |
2.2575 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.2575 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRA2C, APP, AR, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, GPER1, KDR, KIT, NR1H4, PIM1, PPARA, PTPRS, SRC, TERT, THRA, TNKS2, XDH |
2.24495 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, GPER1, IGF1R, MMP2, NR1H4, SRC |
2.23932 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.23511 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, AR, BCL2, CDK6, CYP1B1, DRD2, FABP3, GPER1, TERT, XDH |
2.21682 |
[BP] GO:0010676 |
None
|
ESRRB, GPER1, PPARA, SRC |
2.19305 |
[BP] GO:0019935 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2, GPER1 |
2.18347 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC |
2.18347 |
[BP] GO:0006937 |
None
|
ADORA1, ADRA2A, ADRA2C, CHRM2, GPER1, KIT |
2.17923 |
[BP] GO:0070201 |
None
|
ACHE, ADRA2A, ADRA2C, APP, BCL2, DRD2, GPER1, HCAR2, MMP12, NR1H4, PTPN1, SRC, THRA |
2.17784 |
[BP] GO:0071880 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.17784 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, KIT |
2.17229 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.17229 |
[BP] GO:0002683 |
negative regulation of immune system process
|
ADORA1, ALOX15, AXL, CDK6, CYP19A1, DRD2, GPER1, MMP12, PTPRS |
2.16583 |
[BP] GO:0050714 |
None
|
ACHE, DRD2, GPER1, HCAR2, MMP12, NR1H4, SRC |
2.16328 |
[BP] GO:0043269 |
regulation of ion transport
|
ABCB1, ADORA1, ADRA2A, APP, BCL2, CA2, CA7, DRD1, DRD2, GPER1, MMP9 |
2.15118 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AR, AURKB, AXL, BCL2, CSNK2A1, DNMT1, DRD2, ESR1, ESR2, GPER1, IGF1R, KDR, KIT, MET, MMP1, MMP9, PTPN1, PTPRS, SRC, THRA, TNKS, TNKS2 |
2.14893 |
[BP] GO:0018105 |
peptidyl-serine phosphorylation
|
AURKB, BCL2, DRD1, DYRK1A, SRC, TNKS |
2.13489 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
ADRA2C, APP, AR, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, ESR1, ESRRA, F3, GPER1, KDR, KIT, NR1H4, PIM1, PTPRS, SRC, TERT, XDH |
2.1207 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, DNMT1, FABP3, HSD17B2, KDR, MMP2, NR1H4, SRC |
2.1207 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DNMT1, GPER1, KDR, MET, MMP9, SRC, TNKS, TNKS2 |
2.11832 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, POLB, TYR |
2.11832 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, POLA1, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
2.11832 |
[BP] GO:0035625 |
None
|
ADRA2A, ADRA2C |
2.11832 |
[BP] GO:0032811 |
None
|
ADRA2A, ADRA2C |
2.11832 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.11832 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.11832 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.11832 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, KIT, MMP9, TERT |
2.10721 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP3A4 |
2.08747 |
[BP] GO:1904707 |
positive regulation of vascular smooth muscle cell proliferation
|
MMP2, MMP9, TERT |
2.08747 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.08747 |
[BP] GO:0050995 |
None
|
ADORA1, ADRA2A, HCAR2 |
2.08747 |
[BP] GO:0045944 |
None
|
APP, AR, DRD2, ESR1, ESRRA, ESRRB, GPER1, MET, MMP12, NR1H4, PPARA, TERT, THRA, THRB, TNKS |
2.07756 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.07589 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.07589 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, POLA1, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
2.0703 |
[BP] GO:0050708 |
None
|
ACHE, ADRA2A, ADRA2C, DRD2, GPER1, HCAR2, MMP12, NR1H4, SRC |
2.0656 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, GPER1, HSD11B2, KIT, MMP2, MMP9, NR1H4, POLA1, POLB, PPARA, PTPN1, SRC, TERT, THRA |
2.05001 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.04771 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, APP, AR, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, GPER1, IGF1R, KDR, KIT, MET, MMP12, MMP9, NR1H4, PIM1, POLA1, PPARA, PTPN1, SRC, TERT, THRA, THRB, TNKS, TNKS2, XDH |
2.04721 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.04115 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DNMT1, DRD1, GPER1, IGF1R, MMP2, NR1H4, SRC |
2.04087 |
[BP] GO:1904018 |
positive regulation of vasculature development
|
CYP1B1, F3, GPER1, KDR, KIT, TERT |
2.0391 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AR, AURKB, AXL, BACE1, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DYRK1A, ESR1, F10, F3, FLT3, FUT7, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLB, PPARA, PTPN1, PTPRS, SRC, TNKS, TNKS2 |
2.0391 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.01491 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BACE1, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, F10, FLT3, GBA2, GPER1, HSD11B1, HSD11B2, HSD17B2, HSD17B3, PTPN1, TBXAS1 |
4.29792 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ABCB1, ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPER1, HSD17B3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SHBG, SRC, TERT, THRA, THRB, TNKS, TNKS2, TUBB3, TYR, XDH |
3.39703 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, GBA2, GPER1, HSD11B1, HSD11B2, HSD17B2, HSD17B3, TBXAS1 |
3.33671 |
[CC] GO:0016020 |
membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALOX5, ALPL, APP, AR, AXL, BACE1, BCL2, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DRD1, DRD2, ESR1, F10, F3, FLT3, FUT7, GBA2, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPN1, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TYR |
3.1826 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, APP, AR, AURKB, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CBR1, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DRD1, DRD2, ESR1, ESR2, F10, FABP3, FABP4, FLT3, FUT7, GBA2, GPER1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, KDR, KIT, MMP2, MMP9, PIM1, POLA1, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, TNKS, TNKS2, TYR, XDH |
3.00593 |
[CC] GO:0030424 |
None
|
ADRA2C, APP, BACE1, CA2, DRD2, GPER1, PTPRS, TUBB3 |
2.69846 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRA2A, ADRA2C, APP, AXL, BACE1, CA4, CHRM2, DRD1, DRD2, F10, F3, FLT3, GPER1, IGF1R, KDR, MET, PTPRS |
2.58836 |
[CC] GO:0005886 |
plasma membrane
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, ALOX15, ALPL, APP, AR, AXL, BACE1, CA12, CA14, CA2, CA4, CA9, CHRM2, CSNK2A1, DRD1, DRD2, ESR1, F10, F3, FLT3, GBA2, GPER1, HCAR2, IGF1R, KDR, KIT, MET, MMP2, PIM1, PTPN1, PTPRS, SRC, TERT |
2.5804 |
[CC] GO:0043226 |
organelle
|
ABCB1, ACHE, ADORA1, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA6, CA9, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPER1, HSD17B3, IGF1R, KDR, KIT, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SHBG, SRC, TERT, THRA, THRB, TNKS, TNKS2, TUBB3, TYR, XDH |
2.54016 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.17784 |
[CC] GO:0098793 |
None
|
ADORA1, ADRA2C, APP, CHRM2, DRD2, GPER1 |
2.12177 |
[CC] GO:0043679 |
None
|
ADRA2C, CHRM2, DRD2, GPER1 |
2.1206 |
[CC] GO:0044454 |
None
|
AR, AURKB, CSNK2A1, ESR1, NR1H4, POLA1, TERT, THRB, TNKS, TNKS2 |
2.01803 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, AOX1, APP, AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, PPARA, PTPN1, TBXAS1, THRA, THRB, TNKS, TYR, XDH |
21.8288 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.0857 |
[MF] GO:0043167 |
ion binding
|
ABCB1, ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, HSD17B1, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TUBB3, TYR, XDH |
14.2321 |
[MF] GO:0003824 |
catalytic activity
|
ABCB1, ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, BACE1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DYRK1A, F10, F3, FLT3, FUT7, GBA2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, POLA1, POLB, PTPN1, PTPRS, SRC, TBXAS1, TERT, TNKS, TNKS2, TUBB3, TYR, XDH |
13.5451 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PPARA, THRA, THRB |
10.4438 |
[MF] GO:0004879 |
nuclear receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PPARA, THRA, THRB |
10.4438 |
[MF] GO:0008270 |
zinc ion binding
|
AR, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DNMT1, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR1H4, PPARA, PTPN1, THRA, THRB, TNKS |
10.4438 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
10.1693 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.065 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TYR, XDH |
10.0347 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
AR, ESR1, ESR2, ESRRA, ESRRB, GPER1, NR1H4, PPARA, THRA, THRB |
9.83636 |
[MF] GO:0005496 |
steroid binding
|
AR, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GPER1, HSD11B2, HSD17B1, NR1H4, SHBG |
9.69685 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, TBXAS1, TYR, XDH |
8.90679 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DNMT1, ESR1, ESR2, ESRRA, ESRRB, F10, KIT, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TYR, XDH |
8.58558 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, XDH |
8.16495 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
7.85346 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, TYR |
6.64865 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, XDH |
6.56222 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
6.52696 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
6.50545 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AR, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, GPER1, HSD11B2, HSD17B1, NR1H4, PPARA, SHBG |
6.28337 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, CHRM2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, NR1H4, PPARA, THRA, THRB |
6.26223 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, HSD11B2, HSD17B1, POLA1, SRC, TBXAS1, XDH |
5.83992 |
[MF] GO:0042562 |
hormone binding
|
ACHE, AR, GPER1, HSD17B1, IGF1R, SHBG, THRA, THRB |
5.83992 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC, TBXAS1 |
5.7088 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, CDK6, CHRM2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, NR1H4, PPARA, THRA, THRB |
5.68956 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC, TBXAS1 |
5.46128 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, CHRM2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, NR1H4, PPARA, THRA, THRB |
5.34667 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TBXAS1, TYR |
5.07513 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
4.93659 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.8213 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRA2A, ADRA2C, AR, AXL, CHRM2, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, GPER1, HCAR2, IGF1R, KDR, KIT, MET, NR1H4, PPARA, THRA, THRB |
4.61568 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.60452 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3 |
4.45418 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
4.18694 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.13207 |
[MF] GO:0008144 |
drug binding
|
ABCB1, ACHE, AURKB, AXL, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, PPARA, SRC |
4.01953 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ABCB1, ADORA1, ADRA2A, ADRA2C, AOX1, APP, AR, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, FLT3, GPER1, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, MMP12, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, SHBG, SRC, TBXAS1, TERT, THRA, THRB, TUBB3, XDH |
3.89089 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2, GPER1 |
3.87211 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, KIT, MET |
3.6564 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, SRC |
3.62266 |
[MF] GO:1901338 |
None
|
ADRA2A, ADRA2C, DRD1, DRD2 |
3.61743 |
[MF] GO:0004887 |
None
|
NR1H4, THRA, THRB |
3.42223 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.11319 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.75662 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.75662 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.75662 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, ADRA2A, ADRA2C, AOX1, APP, BCL2, CSNK2A1, DRD2, DYRK1A, ESR1, ESR2, FLT3, IGF1R, KDR, KIT, MET, MMP9, TERT, TYR, XDH |
2.50466 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, ADRA2A, CSNK2A1, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC, THRA |
2.48695 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, SRC |
2.47578 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.43738 |
[MF] GO:0004935 |
None
|
ADRA2A, ADRA2C, DRD2 |
2.43123 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CDK6, CSNK2A1, DYRK1A, FLT3, IGF1R, KDR, KIT, MET, PIM1, POLA1, POLB, SRC, TERT |
2.38768 |
[MF] GO:0019899 |
enzyme binding
|
ADRA2A, APP, AR, AURKB, BACE1, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, CYP3A4, ESR1, ESR2, ESRRB, F3, KIT, MET, POLA1, POLB, PPARA, PTPN1, SRC, THRB, TNKS2 |
2.37569 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.35272 |
[MF] GO:0004938 |
None
|
ADRA2A, ADRA2C |
2.35272 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ADRA2A, ESRRB, FLT3, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC, THRA |
2.3184 |
[MF] GO:0036094 |
small molecule binding
|
ABCB1, ADORA1, AOX1, AURKB, AXL, CDK6, CSNK2A1, DAO, DNMT1, DYRK1A, FABP3, FABP4, FLT3, HSD11B2, HSD17B1, IGF1R, KDR, KIT, MET, NR1H4, PIM1, POLA1, SRC, TUBB3, XDH |
2.26878 |
[MF] GO:0008134 |
transcription factor binding
|
AR, BCL2, ESR1, ESRRB, FLT3, NR1H4, PIM1, PPARA, SRC, TERT, THRA |
2.25062 |
[MF] GO:0001223 |
transcription coactivator binding
|
ESR1, PPARA, TERT |
2.17784 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.11832 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.11832 |
[MF] GO:0032795 |
None
|
ADORA1, ADRA2A |
2.11832 |
[MF] GO:0005497 |
None
|
AR, SHBG |
2.11832 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.11832 |
[MF] GO:0003674 |
molecular_function
|
ABCB1, ACHE, ADORA1, ADORA3, ADRA2A, ADRA2C, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, AOX1, APP, AR, AURKB, AXL, BACE1, BCL2, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CBR1, CDC25B, CDK6, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DAO, DNMT1, DRD1, DRD2, DYRK1A, ESR1, ESR2, ESRRA, ESRRB, F10, F3, FABP3, FABP4, FLT3, FUT7, GBA2, GPER1, HCAR2, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HSD17B3, IGF1R, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NR1H4, PIM1, POLA1, POLB, PPARA, PTPN1, PTPRS, SHBG, SRC, TBXAS1, TERT, THRA, THRB, TNKS, TNKS2, TUBB3, TYR, XDH |
2.10088 |
[MF] GO:0008227 |
None
|
ADRA2A, ADRA2C, CHRM2, DRD2 |
2.08434 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.07589 |